These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2274998)

  • 1. Toxicity of cyclosporine metabolites.
    Copeland KR; Thliveris JA; Yatscoff RW
    Ther Drug Monit; 1990 Nov; 12(6):525-32. PubMed ID: 2274998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive activity of cyclosporine metabolites compared and characterized by mass spectroscopy and nuclear magnetic resonance.
    Copeland KR; Yatscoff RW; McKenna RM
    Clin Chem; 1990 Feb; 36(2):225-9. PubMed ID: 2137384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical significance of cyclosporine metabolites.
    Yatscoff RW; Rosano TG; Bowers LD
    Clin Biochem; 1991 Feb; 24(1):23-35. PubMed ID: 2060129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and biotransformation of the cyclosporine metabolite M-17 in the rabbit.
    Copeland K; Lukowski M; Yatscoff R; Thliveris J; Honcharik N
    Drug Metab Dispos; 1990; 18(2):226-30. PubMed ID: 1971578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The isolation, structural characterization, and immunosuppressive activity of cyclosporin G (NVa2-cyclosporine) metabolites.
    Copeland KR; Yatscoff RW
    Ther Drug Monit; 1991 Jul; 13(4):281-8. PubMed ID: 1780958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of cyclosporin G (OG37-325), cyclosporin A, and their metabolites on the release of endothelin and prostacyclin from primary renal and aortic endothelial cell lines.
    Langman LJ; Yatscoff RW
    Ther Drug Monit; 1994 Oct; 16(5):450-7. PubMed ID: 7846742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships of cyclosporines. Toxicity in cultured renal tubular epithelial cells.
    Walker RJ; Lazzaro VA; Duggin GG; Horvath JS; Tiller DJ
    Transplantation; 1989 Aug; 48(2):321-7. PubMed ID: 2756558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and in vitro characterization of a novel immunosuppressive cyclosporine metabolite.
    Roesel T; LeGrue SJ; Liehr J; Kahan BD
    Transplantation; 1989 Jan; 47(1):149-56. PubMed ID: 2521404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of cyclosporine metabolites in human bile, blood, and urine by high-performance liquid chromatography/radioimmunoassay/fast atomic bombardment mass spectroscopy.
    Cheung F; Wong PY; Loo J; Cole EH; Levy GA
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):602-8. PubMed ID: 3284109
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of cyclosporine and cyclosporine metabolites in experimental small intestinal transplantation.
    Kim PC; Cohen Z; Wong PY; Cole E; Cullen J; Skorecki K; Cheung F; Fung LS; Craig M; Levy GA
    Transplantation; 1990 Jun; 49(6):1043-50. PubMed ID: 2360247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of calcium channel blockers on cyclosporine and its metabolites in renal transplant recipients.
    Tortorice KL; Heim-Duthoy KL; Awni WM; Rao KV; Kasiske BL
    Ther Drug Monit; 1990 Jul; 12(4):321-8. PubMed ID: 2396304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term cyclosporine pharmacokinetic changes in renal transplant recipients: effects of binding and metabolism.
    Awni WM; Kasiske BL; Heim-Duthoy K; Rao KV
    Clin Pharmacol Ther; 1989 Jan; 45(1):41-8. PubMed ID: 2642778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and identification of a novel human metabolite of cyclosporin A: dihydro-CsA M17.
    Meier GP; Park SB; Yee GC; Gmur DJ
    Drug Metab Dispos; 1990; 18(1):68-71. PubMed ID: 1970780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunosuppressive activity of the aldehydic transformation of cyclosporine on alloreactive T-cells.
    Eiras G; Hashem H; Zeevi A; Wong L; Duquesnoy RJ; Burckart GJ
    J Clin Pharmacol; 1991 Jan; 31(1):72-5. PubMed ID: 2045531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass spectrometric analysis of cyclosporine metabolites.
    Hartman NR; Jardine I
    Biomed Environ Mass Spectrom; 1986 Jul; 13(7):362-72. PubMed ID: 2943349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of cyclosporine by a competitive binding assay with cyclophilin.
    Steiner G; Küllinger B; Mayer G; Jie Y; Leibl H; Kovarik J; Woloszczuk W
    Clin Chem; 1991 Mar; 37(3):403-10. PubMed ID: 2004448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis and necrosis: mechanisms of cell death induced by cyclosporine A in a renal proximal tubular cell line.
    Healy E; Dempsey M; Lally C; Ryan MP
    Kidney Int; 1998 Dec; 54(6):1955-66. PubMed ID: 9853260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and in vitro immunosuppressive activity of a SDZ-IMM-125 metabolite isolated from phenobarbital-induced rabbit liver microsomes.
    Dieden R; Verbeeck RK; Maton N; Latinne D; Lhoëst GJ
    Xenobiotica; 1997 Sep; 27(9):933-49. PubMed ID: 9381734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine A nephrotoxicity studied by the combined application of kidney cell lines, hepatocytes, and endothelial-platelet cocultures.
    Vickers A; Guertler J; Spaans C; Tapparelli C; Donatsch P; Fischer V
    Mol Toxicol; 1987-1988 Fall; 1(4):351-61. PubMed ID: 3509690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive activity and toxicity of cyclosporine metabolites characterized by mass spectroscopy and nuclear magnetic resonance.
    Copeland KR; Yatscoff RW
    Transplant Proc; 1990 Jun; 22(3):1146-9. PubMed ID: 2349676
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.